Skip to Main Content

Paper Details

Angiotensin II for the Treatment of High-Output Shock 3 (ATHOS-3): protocol for a phase III, double-blind, randomised controlled trial.
Crit Care Resusc
34
2017
Author NameAffiliation
Lakhmir S ChawlaVeterans Affairs Medical Center
James A RussellUniversity of British Columbia
Sean M BagshawUniversity of Alberta
Andrew D ShawVanderbilt University Medical Center
Stuart L GoldsteinCenter for Acute Care Nephrology, Cincinnati Children's Hospital Medical Center
Mitchell P FinkDavid Geffen School of Medicine, University of California los angeles
George F TidmarshLa Jolla Pharmaceutical Company
  • 1 - 7

Datasets

Release 1.2